M2Bio Rolls Out Sustainable Packaging for Liviana
Wuhan General Group, Inc. (WUHN) has announced the rollout of its innovative sustainable packaging solution, Hempcelium™, through its Liviana™ Extra Virgin Olive Oil brand. This unique packaging, made from hemp agri-waste and mushroom mycelium, is designed to significantly reduce environmental impact by being biodegradable and low in carbon footprint. The development of Hempcelium™ is part of M2Bio Sciences’ commitment to sustainability, with plans to license the technology globally. The company anticipates completion of legal processes for the trademark in Q1 2022.
- Launch of Hempcelium™ sustainable packaging for Liviana™ brand.
- Hempcelium™ packaging made from eco-friendly materials reduces environmental impact.
- Anticipated global licensing of the Hempcelium™ technology aims to replace synthetic materials.
- None.
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / December 31, 2021 /WUHAN GENERAL GROUP, INC. (WUHN) ("WGG'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and mental health therapeutic research is pleased to share the following update:
M2Bio Sciences is pleased to announce the rollout of its sustainable packaging solution - Hempcelium™ to be piloted and implemented by it's Liviana™ Extra Virgin Olive Oil brand. The state-of-the-art sustainable packaging is customized to fit its Extra Virgin Olive Oil glass bottles. The solution is a Hempcelium™ transport packaging foam made from hemp agri-waste and mushroom mycelium.
Hempcelium™ is a unique composite that outperforms most other sustainable alternatives currently available. The Hempcelium™ packaging structure is completely organic and can be grown into almost any shape, making it as versatile as styrofoam or polystyrene, less the damage and pollution that comes from using a conventional synthetic material. Because Hempcelium™ is grown and not produced with chemical compounds that need large amounts of energy to synthesize, the carbon footprint is very low, and there are zero industrial chemical byproducts emitted that are harmful to the natural environment, our water, ecosystems, food-chains and human health.
The unique Hempcelium™ composite has been developed in-house by its team of engineers at the M2Bio Sustainability Labs during 2021 and is ready for the South African market. The company is in the process of obtaining all necessary legal and copyrights pertaining to the trademark name Hempcelium™. M2Bio Sciences' Intellectual Property and Trademark legal team expects the process to be successfully concluded in Q1 2022.
"When you get the product with the packaging you are able to crumble up the Hempcelium™ foam into your garden bed or soil to decompose and support the health of your vegetation. Hempcelium serves an important function in the decomposition of organic matter in the soil. Research has demonstrated that it acts as a filter, removing groundwater contaminants and pollutants. It has shown potential to remove industrial toxins from the soil, which includes pesticides, chlorine, dioxin (a highly toxic environmental pollutant) as well as PCBs (highly toxic industrial compounds). In the garden, Hempcelium helps to increase nutrients available to plants, improve water efficiency, reduce erosion by acting as a cellular net, and promote root growth by adding oxygen to the soil and releasing nitrogen, phosphate, and other micronutrients. Simply put, it has a ton of benefits." - Jeff Robinson, CEO of M2Bio Sciences.
Hempcelium™ packaging solution for single & multiple bottles
Mr. Robinson continues: "We and our customers are increasingly aware of the importance of sustainable and biodegradable materials. As a company, it has been at the core of product development to ensure all of our materials and ingredients adhere to such standards. We are now proud to take it to the next level, and deliver our own innovative solution to our customers, by introducing our sustainable packaging foam to one of our brands, Liviana."
In addition, M2Bio is developing multiple packaging solutions for its other product lines and brands - Medspresso™ and Dr. AnnaRx™, which will be ready during the course of 2022.
"This will be a watershed moment for the sustainability drive globally. M2Bio will licence the technology to the rest of the world, with the goal of reducing and replacing synthetics entirely. We are super stoked for what comes next'' - Jeff Robinson, CEO of M2Bio Sciences.
Hempcelium™ packaging solution for Dr. AnnaRx products
About Wuhan General Group, Inc./ M2Bio Sciences, Inc
Wuhan General Group, Inc. (DBA M2bio Sciences), through its wholly-owned subsidiary MJ MedTech is a nutraceutical biotechnology company focused on alternative plant-based cannabinoids and psilocybin medical research that develops and commercializes a range of CBD and mushrooms-based products under Dr. AnnaRx™, Medspresso™, and Liviana™ brands. In addition, our research and clinical trials with psilocybin are aimed at new therapies that will help patients who suffer from alcohol addiction, mental illness, and cardiovascular diseases. Our mission is to advance botanical-based medicine to the forefront by deploying best-practice science and medicine, clinical research, and emerging technologies. The Company is traded on the Over-the-Counter Bulletin Board of NASDAQ under the trading symbol "WUHN".
Publicly traded company (OTC Pink: WUHN)
Website: www.m2bio.co
E-mail: info@m2bio.co
Follow us on Twitter: https://twitter.com/m2bio
Follow us on Facebook: http://www.facebook.com/m2bio
Follow us on YouTube: https://www.youtube.com/channel/M2BioSciences
Follow us on Instagram: https://www.instagram.com/m2bio.sciences/
Forward-Looking Statements:
Safe Harbour Statement - In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company's future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and involve risks and uncertainties and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company's business units or the market price of its common stock. Additional factors that could cause actual results to differ materially from those contemplated within this press release can also be found on the Company's website. The Company disclaims any responsibility to update any forward-looking statements.
SOURCE: Wuhan General Group, Inc./ M2Bio Sciences, Inc.
View source version on accesswire.com:
https://www.accesswire.com/680355/M2Bio-Rolls-Out-Sustainable-Packaging-for-Liviana
FAQ
What is Hempcelium™ and how is it used by WUHN?
When is WUHN expected to finalize the trademark for Hempcelium™?
How does Hempcelium™ benefit the environment?
Will WUHN expand the use of Hempcelium™ packaging to other products?
What are the main goals of M2Bio Sciences regarding Hempcelium™?
